Anna Fakadej, MD
Ophthalmology · Southern Pines, NCNPI 1932190261
Payments from drug & device makers
Across 598 payments — averaging $506.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$203K
- Kala Pharmaceuticals, Inc.$69K
- Alcon$16K
- Bausch Health US, LLC$14K
- Rxsight Inc$174
- Biotissue Holdings Inc.$162
- plus $297 from 6 others
What the payments were for
- Consulting fees$2,94016%
- Speaking & faculty fees$12,39569%
- Travel & lodging$1751%
- Food & beverage$2,39913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 512 | $202,849 |
| Kala Pharmaceuticals, Inc. | 8 | $69,250 |
| Alcon | 54 | $16,296 |
| Bausch Health US, LLC | 3 | $13,800 |
| Rxsight Inc | 3 | $174 |
| Biotissue Holdings Inc. | 9 | $162 |
| Glaukos Corporation | 3 | $108 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $101 |
| Bausch & Lomb Americas Inc. | 2 | $44 |
| AbbVie | 1 | $16 |
| Ivantis, Inc | 1 | $14 |
| Rayner Intraocular Lenses Limited | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$14,530
- Hydrus Microstent$145
- DAILIES TOTAL1$125
- Tecnis Simplicity$101
- TOTAL30$100
How this compares
$302,828 in reported general payments places this provider in the 95th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 828 | $29,655 |
| Difluprednate | 255 | $26,627 |
| Ofloxacin | 1,133 | $13,252 |
| Brimonidine Tartrate | 20 | $431 |
| Timolol Maleate | 55 | $423 |
| Gentamicin Sulfate | 54 | $401 |
| Latanoprost | 38 | $304 |
| Ketorolac Tromethamine | 13 | $245 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Southern Pines
- Arghavan AlmonySouthern Pines$403K
- Tarra MillenderSouthern Pines$31K
- Winston GarrisSouthern Pines$25K
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Andrew AntoszykCharlotte$4M
- Majda HadziahmetovicDurham$2.4M
- Preeya GuptaRaleigh$2M
- Thomas WilliamsHickory$1.8M
- James HarrisHickory$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.